Olmesartan/Amlodipine Krka d.d. Novo Mesto 40 mg - 10 mg film-coat. tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

olmesartan/amlodipine krka d.d. novo mesto 40 mg - 10 mg film-coat. tabl.

krka d.d. novo mesto d.d. - olmesartan medoxomil 40 mg; amlodipine besilate 13,88 mg - eq. amlodipine 10 mg - film-coated tablet - 40 mg - 10 mg - olmesartan medoxomil 40 mg; amlodipine besilate 13.88 mg - olmesartan medoxomil and amlodipine

Olmesartan/Amlodipine Krka d.d. Novo Mesto 40 mg - 5 mg film-coat. tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

olmesartan/amlodipine krka d.d. novo mesto 40 mg - 5 mg film-coat. tabl.

krka d.d. novo mesto d.d. - olmesartan medoxomil 40 mg; amlodipine besilate 6,94 mg - eq. amlodipine 5 mg - film-coated tablet - 40 mg - 5 mg - olmesartan medoxomil 40 mg; amlodipine besilate 6.94 mg - olmesartan medoxomil and amlodipine

Lenalidomide Krka d.d. European Union - English - EMA (European Medicines Agency)

lenalidomide krka d.d.

krka, d.d., novo mesto  - lenalidomide hydrochloride hydrate - multiple myeloma; lymphoma, follicular; myelodysplastic syndromes - immunosuppressants - multiple myelomalenalidomide krka d.d. as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation.lenalidomide krka d.d. as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4.2) is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for transplant.lenalidomide krka d.d. in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy.myelodysplastic syndromeslenalidomide krka d.d. as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate.follicular lymphomalenalidomide krka d.d. in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

Duloxetine Krka 30 mg hard gastro-resistant capsules Ireland - English - HPRA (Health Products Regulatory Authority)

duloxetine krka 30 mg hard gastro-resistant capsules

krka, d.d., novo mesto - duloxetine - gastro-resistant capsule, hard - 30 milligram(s) - other antidepressants; duloxetine - psychoanaleptics, other antidepressants - treatment of major depressive disorder. treatment of diabetic peripheral neuropathic pain. treatment of generalised anxiety disorder.

Duloxetine Krka 60 mg hard gastro-resistant capsules Ireland - English - HPRA (Health Products Regulatory Authority)

duloxetine krka 60 mg hard gastro-resistant capsules

krka, d.d., novo mesto - duloxetine - gastro-resistant capsule, hard - 60 milligram(s) - other antidepressants; duloxetine - psychoanaleptics, other antidepressants - treatment of major depressive disorder. treatment of diabetic peripheral neuropathic pain. treatment of generalised anxiety disorder.

Amoxicillin/clavulanic acid Krka 500 mg/125 mg Film-Coated Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

amoxicillin/clavulanic acid krka 500 mg/125 mg film-coated tablets

krka, d.d., novo mesto - amoxicillin; clavulanic acid - film-coated tablet - 500 mg/ 125 milligram(s) - combinations of penicillins, incl. beta-lactamase inhibitors; amoxicillin and enzyme inhibitor - : antibacterials for systemic use, combinations of penicillins, incl. beta-lactamase inhibitors - - acute bacterial sinusitis (adequately diagnosed) - acute otitis media - acute exacerbations of chronic bronchitis (adequately diagnosed) - community acquired pneumonia - cystitis - pyelonephritis - skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis. - bone and joint infections, in particular osteomyelitis.

Bortezomib Krka 1 mg powder for solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

bortezomib krka 1 mg powder for solution for injection

krka, d.d., novo mesto - bortezomib - powder for solution for injection - 1 milligram(s) - bortezomib

Bortezomib Krka 3.5 mg powder for solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

bortezomib krka 3.5 mg powder for solution for injection

krka, d.d., novo mesto - bortezomib - powder for solution for injection - 3.5 milligram(s) - bortezomib

Olmesartan/Hydrochlorothiazide Krka 40 mg/25 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

olmesartan/hydrochlorothiazide krka 40 mg/25 mg film-coated tablets

krka, d.d., novo mesto - olmesartan medoxomil; hydrochlorothiazide - film-coated tablet - 40 mg/25 milligram(s) - angiotensin ii antagonists and diuretics; olmesartan medoxomil and diuretics

Olmesartan/Hydrochlorothiazide Krka 40 mg/12.5 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

olmesartan/hydrochlorothiazide krka 40 mg/12.5 mg film-coated tablets

krka, d.d., novo mesto - olmesartan medoxomil; hydrochlorothiazide - film-coated tablet - 40 mg/12.5 milligram(s) - angiotensin ii antagonists and diuretics; olmesartan medoxomil and diuretics